Infections in patients with inflammatory bowel disease receiving anti-tumor necrosis factor agents are not associated with higher serum drug levels

被引：0
|
作者：
Chu, I. E. [1 ,2 ]
Su, H. Y. [1 ,2 ]
Martin, C. [3 ]
Sparrow, M. P. [1 ,2 ]
机构：
[1] Alfred Hosp, Alfred Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
[3] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [1] The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease
    Koutroubakis, Ioannis E.
    Ramos-Rivers, Claudia
    Regueiro, Miguel
    Koutroumpakis, Efstratios
    Click, Benjamin
    Schwartz, Marc
    Swoger, Jason
    Baidoo, Leonard
    Hashash, Jana G.
    Barrie, Arthur
    Dunn, Michael A.
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1587 - 1593
  • [2] Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents
    Hung-Viet Pham
    Hasan, Imran
    Udaltsova, Natalia
    Pham, Kathy
    Abramson, Oren
    Armstrong, Mary Anne
    Postlethwaite, Debbie
    Li, Dan
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (01) : 209 - 217
  • [3] Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents
    Hung-Viet Pham
    Imran Hasan
    Natalia Udaltsova
    Kathy Pham
    Oren Abramson
    Mary Anne Armstrong
    Debbie Postlethwaite
    Dan Li
    Digestive Diseases and Sciences, 2018, 63 : 209 - 217
  • [4] Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
    Yunho, Jung
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (01): : 1 - 3
  • [5] Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease
    Kim, Ju Young
    Lee, Yoon
    Choe, Byung-Ho
    Kang, Ben
    GUT AND LIVER, 2021, 15 (04) : 588 - 598
  • [6] Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
    Park, Jihye
    Cheon, Jae Hee
    GUT AND LIVER, 2021, 15 (05) : 641 - 642
  • [7] Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases
    Yarur, Andres J.
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1709 - 1718
  • [8] Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
    Mahadevan, Uma
    Wolf, Douglas C.
    Dubinsky, Marla
    Cortot, Antoine
    Lee, Scott D.
    Siegel, Corey A.
    Ullman, Thomas
    Glover, Sarah
    Valentine, John F.
    Rubin, David T.
    Miller, Jocelyn
    Abreu, Maria T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (03) : 286 - 292
  • [9] Reversal of Immunogenicity in Pediatric Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Medications
    Kang, Elise
    Khalili, Ali
    Splawski, Judy
    Sferra, Thomas J.
    Moses, Jonathan
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2018, 21 (04) : 329 - 335
  • [10] Psoriasis Associated With Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Cullen, Garret
    Kroshinsky, Daniela
    Cheifetz, Adam S.
    Korzenik, Joshua R.
    GASTROENTEROLOGY, 2011, 140 (05) : S774 - S775
12345